v3.25.3
FINANCIAL INSTRUMENTS
 9 Months Ended
Sep. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
FINANCIAL INSTRUMENTS FINANCIAL INSTRUMENTS
The Company’s financial instruments include cash and cash equivalents, marketable securities and accounts receivable. Due to the short-term nature of these instruments, their book value approximates their fair value. The Company’s financial instruments may also include long-term debt, investments in equity securities, interest rate and cross-currency swaps, commodity derivative contracts and foreign currency derivative contracts. All derivative contracts are placed with counterparties that have an S&P, or equivalent, investment grade credit rating at the time of the contracts’ placement. An adjustment for non-performance risk is considered in the estimate of fair value in derivative assets based on the counterparty credit default swap (“CDS”) rate. When the Company is in a net derivative liability position, the non-performance risk adjustment is based on its CDS rate. At September 30, 2025 and December 31, 2024, the Company had no derivative contracts that contained credit-risk-related contingent features.

Cash Flow Hedges

The Company, at times, uses certain commodity derivative contracts to protect against commodity price changes related to forecasted raw material and component purchases. At September 30, 2025 and December 31, 2024, the Company had no material commodity derivative contracts.

The Company manages its interest rate risk by balancing its exposure to fixed and variable rates while attempting to optimize its interest costs. The Company, at times, selectively uses interest rate swaps and options to reduce market value risk associated with changes in interest rates. At September 30, 2025 and December 31, 2024, the Company had no outstanding interest rate swaps or options.

The Company uses foreign currency forward and option contracts to protect against exchange rate movements for forecasted cash flows, including capital expenditures, purchases, operating expenses or sales transactions designated in currencies other than the functional currency of the operating unit. Foreign currency derivative contracts require the Company, at a future date, to either buy or sell foreign currency in exchange for the operating units’ local currency.
Effectiveness for cash flow hedges is assessed at the inception of the hedging relationship and quarterly, thereafter. Gains and losses arising from these contracts that are included in the assessment of effectiveness are deferred into accumulated other comprehensive income (loss) (“AOCI”) and reclassified into income as the underlying operating transactions are recognized. These realized gains or losses offset the hedged transaction and are recorded on the same line in the statement of operations. The initial value of any component excluded from the assessment of effectiveness is recognized in income using a systematic and rational method over the life of the hedging instrument. Any difference between the change in fair value of the excluded component and amounts recognized in income under that systematic and rational method is recognized in AOCI.

At September 30, 2025, the following notional amounts related to foreign currency derivative contracts were outstanding, which mature through September 2027:
(in millions)Notional Amount*
Traded CurrencyNotional in Traded CurrencyNotional in Approximate U.S. Dollar
Euro352 $412 
U.S. Dollar394 $394 
Mexican Peso3,110 $169 
Polish Zloty606 $166 
Korean Won56,911 $40 
Swiss Franc30 $38 
Hungarian Forint11,738 $35 
British Pound23 $31 
*Table above excludes non-significant traded currency with total notional amounts less than $10 million U.S. Dollar equivalent as of September 30, 2025.

Net Investment Hedges

In addition, the Company is also exposed to the risk that adverse changes in foreign currency exchange rates could impact its net investment in non-U.S. subsidiaries.

The Company selectively uses cross-currency swaps to hedge that foreign currency exposure. At September 30, 2025 and December 31, 2024, the following cross-currency swap contracts were outstanding and mature through August 2030:
Cross-currency swaps
(in millions)September 30, 2025December 31, 2024
U.S. Dollar to Euro:
Fixed receiving notional$400 $1,100 
Fixed paying notional€355 €976 
U.S. Dollar to Euro:
Fixed receiving notional$500 $— 
Fixed paying notional€450 €— 
U.S. Dollar to Euro:
Fixed receiving notional$200 $— 
Fixed paying notional€179 €— 
U.S. Dollar to Euro:
Fixed receiving notional$500 $500 
Fixed paying notional€470 €470 
U.S. Dollar to Japanese yen:
Fixed receiving notional$100 $100 
Fixed paying notional¥12,724 ¥12,724 

During the nine months ended September 30, 2025, the Company unwound $700 million of cross-currency swap contracts originally maturing in July 2027, resulting in a cash outflow of approximately $4 million. The corresponding loss is expected to remain in accumulated other comprehensive income until the net investment is sold, completely liquidated or substantially liquidated. Concurrently, the Company executed two U.S. Dollar to Euro cross-currency swap contracts of $500 million maturing in July 2028 and $200 million maturing in August 2030.

In addition, the Company has designated the €1,000 million 1.000% Senior Notes due May 19, 2031, as a net investment hedge of the foreign currency exposure of its investments in certain Euro-denominated subsidiaries. Refer to Note 13, “Debt,” to the Condensed Consolidated Financial Statements for more information.

The Company assesses the effectiveness for net investment hedges at the inception of the hedging relationship and quarterly, thereafter. Gains and losses arising from these contracts that are included in the assessment of effectiveness are deferred into foreign currency translation adjustments and only released when the subsidiary being hedged is sold or substantially liquidated. The initial value of any component excluded from the assessment of effectiveness is recognized in income using a systematic and rational method over the life of the hedging instrument. Any difference between the change in fair value of the excluded component and amounts recognized in income under that systematic and rational method is recognized in AOCI.
Fair Value of Derivative Instruments in the Balance Sheet

At September 30, 2025 and December 31, 2024, the following amounts were recorded in the Condensed Consolidated Balance Sheets as being payable to or receivable from counterparties for derivative instruments under ASC Topic 815, “Derivatives and Hedging”:
(in millions)AssetsLiabilities
Derivatives designated as hedging instruments Under 815:LocationSeptember 30, 2025December 31, 2024LocationSeptember 30, 2025December 31, 2024
Foreign currencyPrepayments and other current assets$15 $18 Other current liabilities$16 $23 
Foreign currencyOther non-current assets$3 $5 Other non-current liabilities$4 $5 
Net investment hedgesOther non-current assets$17 $84 Other non-current liabilities$98 $— 
Derivatives not designated as hedging instruments:
Foreign currencyPrepayments and other current assets$— $1 Other current liabilities$— $4 

Effect of Derivatives on the Statements of Operations and Statements of Comprehensive Income (Loss)

The table below shows deferred gains (losses) reported in AOCI as well as the amount expected to be reclassified to income in one year or less for designated hedges. The amount expected to be reclassified to income in one year or less assumes no change in the current relationship of the hedged item at September 30, 2025 market rates.
(in millions)Deferred gain (loss) in AOCI atGain (loss) expected to be reclassified to income in one year or less
Contract TypeSeptember 30, 2025December 31, 2024
Cash flow hedges:
Foreign currency$1 $(7)$(1)
Net investment hedges:
    Cross-currency swaps$(82)$84 $— 
    Foreign currency-denominated debt31 168 — 
Total$(50)$245 $(1)
Derivative instruments designated as hedging instruments as defined by ASC Topic 815 held during the period resulted in the gains and losses recorded in income shown in the table below.
Three Months Ended September 30, 2025
(in millions)Net salesCost of salesSelling, general and administrative expensesOther comprehensive income (loss)
Total amounts of earnings and other comprehensive income (loss) line items in which the effects of cash flow hedges are recorded$3,591 $2,927 $341 $30 
Gain (loss) on cash flow hedging relationships:
Foreign currency:
Gain (loss) recognized in other comprehensive income$(11)
Gain (loss) reclassified from AOCI to income$1 $(2)$— $— 
Nine Months Ended September 30, 2025
(in millions)Net salesCost of salesSelling, general and administrative expensesOther comprehensive income (loss)
Total amounts of earnings and other comprehensive income (loss) line items in which the effects of cash flow hedges are recorded$10,744 $8,801 $973 $182 
Gain (loss) on cash flow hedging relationships:
Foreign currency:
Gain (loss) recognized in other comprehensive income$— 
Gain (loss) reclassified from AOCI to income$1 $(8)$(2)$— 
Three Months Ended September 30, 2024
(in millions)Net salesCost of salesSelling, general and administrative expensesOther comprehensive income (loss)
Total amounts of earnings and other comprehensive income (loss) line items in which the effects of cash flow hedges are recorded$3,449 $2,813 $340 $130 
Gain (loss) on cash flow hedging relationships:
Foreign currency:
Gain (loss) recognized in other comprehensive income$23 
Gain (loss) reclassified from AOCI to income$1 $4 $— $— 
Nine Months Ended September 30, 2024
(in millions)Net salesCost of salesSelling, general and administrative expensesOther comprehensive income (loss)
Total amounts of earnings and other comprehensive income (loss) line items in which the effects of cash flow hedges are recorded$10,647 $8,682 $1,010 $20 
Gain (loss) on cash flow hedging relationships:
Foreign currency:
Gain (loss) recognized in other comprehensive income$19 
Gain (loss) reclassified from AOCI to income$1 $26 $— $— 

The were no gains or losses recorded in income related to components excluded from the assessment of effectiveness for derivative instruments designated as cash flow hedges for the periods presented.

Gains and losses on derivative instruments designated as net investment hedges were recognized in other comprehensive income (loss) during the periods presented below.

(in millions)Three Months Ended September 30,Nine Months Ended September 30,
Net investment hedges2025202420252024
Cross-currency swaps$27 $(33)$(166)$5 
Foreign currency-denominated debt$(3)$(42)$(137)$(10)

Derivatives designated as net investment hedge instruments, as defined by ASC Topic 815, held during the period resulted in the following gains recorded in Interest expense on components excluded from the assessment of effectiveness:
(in millions)Three Months Ended September 30,Nine Months Ended September 30,
Net investment hedges2025202420252024
Cross-currency swaps$6 $6 $18 $17 
There were no gains or losses recorded in income related to components excluded from the assessment of effectiveness for foreign currency-denominated debt designated as net investment hedges. There were no gains and losses reclassified from AOCI for net investment hedges during the periods presented.
Derivatives Not Designated as Hedges

Derivatives not designated as hedging instruments are used to hedge remeasurement exposures of monetary assets and liabilities denominated in currencies other than the operating units’ functional currency. These derivatives resulted in gains (losses) recorded in income as shown in the table below.
(in millions)Three Months Ended September 30,Nine Months Ended September 30,
Contract TypeLocation2025202420252024
Foreign currencySelling, general and administrative expenses$1 $1 $(2)$1